Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.
- NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_assertion description "[Compared with the drug-resistance group, the Ca2+ concentration in cells and the expression of LRP in lung cancer drug-resistance cells A549/DDP of the high-dose group, the low-dose group and the normal group of Chinese medicine were significantly different (all P<0.01), the LRP expression of the normal group was obviously higher than that of the drug-resistance group (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.
- NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_assertion evidence source_evidence_literature NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.
- NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_assertion SIO_000772 18219453 NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.
- NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_assertion wasDerivedFrom befree-20140225 NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.
- NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_assertion wasGeneratedBy ECO_0000203 NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP790493.RAgicLcHUr1O8592N0vVAxN6NTGpLbYpPjLiKQrsUSahg130_provenance.